Literature DB >> 16157591

Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.

Mark Kristiansen1, Marcus J Messenger, Peter-Christian Klöhn, Sebastian Brandner, Jonathan D F Wadsworth, John Collinge, Sarah J Tabrizi.   

Abstract

The molecular basis for neuronal death in prion disease is not established, but putative pathogenic roles for both disease-related prion protein (PrP(Sc)) and accumulated cytosolic PrP(C) have been proposed. Here we report that only prion-infected neuronal cells become apoptotic after mild inhibition of the proteasome, and this is strictly dependent upon sustained propagation of PrP(Sc). Whereas cells overexpressing PrP(C) developed cytosolic PrP(C) aggregates, this did not cause cell death. In contrast, only in prion-infected cells, mild proteasome impairment resulted in the formation of large cytosolic perinuclear aggresomes that contained PrP(Sc), heat shock chaperone 70, ubiquitin, proteasome subunits, and vimentin. Similar structures were found in the brains of prion-infected mice. PrP(Sc) aggresome formation was directly associated with activation of caspase 3 and 8, resulting in apoptosis. These data suggest that neuronal propagation of prions invokes a neurotoxic mechanism involving intracellular formation of PrP(Sc) aggresomes. This, in turn, triggers caspase-dependent apoptosis and further implicates proteasome dysfunction in the pathogenesis of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157591     DOI: 10.1074/jbc.M506600200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Direct evidence of generation and accumulation of β-sheet-rich prion protein in scrapie-infected neuroblastoma cells with human IgG1 antibody specific for β-form prion protein.

Authors:  Toshiya Kubota; Yuta Hamazoe; Shuhei Hashiguchi; Daisuke Ishibashi; Kazuyuki Akasaka; Noriyuki Nishida; Shigeru Katamine; Suehiro Sakaguchi; Ryota Kuroki; Toshihiro Nakashima; Kazuhisa Sugimura
Journal:  J Biol Chem       Date:  2012-02-22       Impact factor: 5.157

2.  Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells.

Authors:  Monique Provansal; Stéphane Roche; Manuela Pastore; Danielle Casanova; Maxime Belondrade; Sandrine Alais; Pascal Leblanc; Otto Windl; Sylvain Lehmann
Journal:  Prion       Date:  2010-10-27       Impact factor: 3.931

3.  Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP.

Authors:  Angelika S Rambold; Margit Miesbauer; Doron Rapaport; Till Bartke; Michael Baier; Konstanze F Winklhofer; Jörg Tatzelt
Journal:  Mol Biol Cell       Date:  2006-05-17       Impact factor: 4.138

4.  Prolyl hydroxylase PHD3 activates oxygen-dependent protein aggregation.

Authors:  Krista Rantanen; Juha Pursiheimo; Heidi Högel; Virpi Himanen; Eric Metzen; Panu M Jaakkola
Journal:  Mol Biol Cell       Date:  2008-03-12       Impact factor: 4.138

5.  Low density subcellular fractions enhance disease-specific prion protein misfolding.

Authors:  James F Graham; Sonya Agarwal; Dominic Kurian; Louise Kirby; Teresa J T Pinheiro; Andrew C Gill
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

6.  Proteasome inhibition by fellutamide B induces nerve growth factor synthesis.

Authors:  John Hines; Michael Groll; Margaret Fahnestock; Craig M Crews
Journal:  Chem Biol       Date:  2008-05

7.  Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.

Authors:  Max Nunziante; Kerstin Ackermann; Kim Dietrich; Hanna Wolf; Lars Gädtke; Sabine Gilch; Ina Vorberg; Martin Groschup; Hermann M Schätzl
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

8.  Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.

Authors:  Pelagia Deriziotis; Ralph André; David M Smith; Rob Goold; Kerri J Kinghorn; Mark Kristiansen; James A Nathan; Rina Rosenzweig; Dasha Krutauz; Michael H Glickman; John Collinge; Alfred L Goldberg; Sarah J Tabrizi
Journal:  EMBO J       Date:  2011-07-08       Impact factor: 11.598

Review 9.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  Identification of novel SHPS-1-associated proteins and their roles in regulation of insulin-like growth factor-dependent responses in vascular smooth muscle cells.

Authors:  Xinchun Shen; Gang Xi; Yashwanth Radhakrishnan; David R Clemmons
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.